Yanxin Luo

15PUBLICATIONS
32CO-AUTHORS
Tumour immunologyCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markersHaematology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|May 25, 2026
ICIsAtlas reveals a suppressive NK cell niche in pan-cancer immunotherapy profiles.

|Feb 13, 2026
CLK1 Promotes Myeloid-Derived Suppressor Cell Trafficking and Reprograms the Tumor Microenvironment by Activating Hippo/YAP Signaling in Colorectal Cancer.

Peisi Li, Yumo Xie, Dawang Zhou

|Jan 21, 2026
Neoadjuvant chemoradiotherapy plus sintilimab in proficient mismatch repair locally advanced rectal cancer with intermediate/high-immunoscore (SILAR): a single-arm phase II trial.

Xiaobin Zheng, Huashan Liu, Lishuo Shi

|Nov 11, 2024
Targeting G-quadruplex by TMPyP4 for inhibition of colorectal cancer through cell cycle arrest and boosting anti-tumor immunity.

Peisi Li, Dawang Zhou, Yumo Xie

|Mar 13, 2024
Neoadjuvant chemotherapy is noninferior to chemoradiotherapy for early-onset locally advanced rectal cancer in the FOWARC trial.

Jinlin Cai, Kaixin Lin, Tongfeng Luo

|Jan 05, 2023
Silence of a dependence receptor CSF1R in colorectal cancer cells activates tumor-associated macrophages.

Mingxuan Zhu, Liangliang Bai, Xiaoxia Liu

Pageof 3

Frequent Collaborators

10 joint publications

Huichuan Yu

5 joint publications

Xiaolin Wang

4 joint publications

Yumo Xie

2 joint publications

Zenghong Huang